我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
57
24 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
7
12.3%
已完成
18
31.6%
尚未招募
17
29.8%
招募中
14
24.6%
暂停
1
1.8%
暂无批准数据
- A 12-week pilot trial in 58 seniors with moderate depression found that a daily probiotic alongside standard antidepressants led to greater reductions in depression and anxiety symptoms versus placebo. - Both the probiotic and placebo groups showed substantial improvement, but the probiotic group experienced modestly greater symptom relief, with no significant difference in overall quality of life. - Researchers also tracked serum BDNF levels and fecal microbiota profiles, finding biological changes that supported the gut-brain axis hypothesis in mental health. - The study authors are planning a larger-scale follow-up clinical trial based on these encouraging preliminary findings.
